CIBC Asset Management’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$16.7M Buy
78,671
+5,774
+8% +$1.13M 0.04% 314
2026
Q1
$14.3M Sell
72,897
-19,232
-21% -$3.74M 0.03% 311
2025
Q4
$16M Buy
92,129
+10,478
+13% +$1.91M 0.04% 294
2025
Q3
$15.5M Buy
81,651
+750
+0.9% +$133K 0.05% 244
2025
Q2
$14.5M Buy
80,901
+11,883
+17% +$2.06M 0.04% 247
2025
Q1
$11.7M Buy
69,018
+29,813
+76% +$4.9M 0.04% 277
2024
Q4
$5.91M Buy
39,205
+816
+2% +$127K 0.02% 380
2024
Q3
$5.95M Buy
38,389
+619
+2% +$92.4K 0.02% 375
2024
Q2
$5.17M Sell
37,770
-942
-2% -$129K 0.02% 371
2024
Q1
$5.15M Buy
38,712
+158
+0.4% +$20.5K 0.02% 384
2023
Q4
$5.32M Sell
38,554
-1,383
-3% -$182K 0.02% 364
2023
Q3
$4.87M Sell
39,937
-581
-1% -$77.4K 0.02% 369
2023
Q2
$5.7M Sell
40,518
-706
-2% -$97.3K 0.02% 345
2023
Q1
$5.83M Sell
41,224
-337
-0.8% -$48.2K 0.02% 343
2022
Q4
$6.5M Buy
41,561
+25,471
+158% +$3.66M 0.03% 311
2022
Q3
$1.97M Buy
16,090
+685
+4% +$90.2K 0.01% 537
2022
Q2
$2.05M Sell
15,405
-14,242
-48% -$1.94M 0.01% 510
2022
Q1
$4.06M Sell
29,647
-2,307
-7% -$322K 0.01% 401
2021
Q4
$5.53M Sell
31,954
-86
-0.3% -$13.1K 0.02% 363
2021
Q3
$4.66M Buy
32,040
+785
+3% +$115K 0.02% 366
2021
Q2
$4.13M Buy
31,255
+2,538
+9% +$332K 0.02% 387
2021
Q1
$3.69M Buy
28,717
+4,769
+20% +$588K 0.02% 378
2020
Q4
$2.85M Buy
23,948
+890
+4% +$108K 0.01% 406
2020
Q3
$2.64M Buy
23,058
+664
+3% +$78.5K 0.01% 376
2020
Q2
$2.55M Buy
22,394
+578
+3% +$61.3K 0.02% 361
2020
Q1
$1.75M Buy
21,816
+6,900
+46% +$714K 0.01% 406
2019
Q4
$1.59M Buy
14,916
+19
+0.1% +$1.98K 0.01% 508
2019
Q3
$1.59M Sell
14,897
-571
-4% -$58.6K 0.01% 486
2019
Q2
$1.57M Sell
15,468
-698
-4% -$67.1K 0.01% 493
2019
Q1
$1.45M Sell
16,166
-955
-6% -$82.8K 0.01% 503
2018
Q4
$1.43M Sell
17,121
-198
-1% -$18.6K 0.01% 457
2018
Q3
$1.87M Sell
17,319
-187
-1% -$20.5K 0.01% 441
2018
Q2
$1.93M Buy
17,506
+379
+2% +$39.5K 0.01% 419
2018
Q1
$1.72M Sell
17,127
-860
-5% -$88.1K 0.01% 441
2017
Q4
$1.77M Sell
17,987
-715
-4% -$67.8K 0.01% 442
2017
Q3
$1.75M Buy
18,702
+285
+2% +$30.3K 0.01% 431
2017
Q2
$2.05M Buy
18,417
+10
+0.1% +$1.06K 0.01% 393
2017
Q1
$1.81M Sell
18,407
-1,227
-6% -$117K 0.01% 420
2016
Q4
$1.8M Sell
19,634
-96
-0.5% -$8.27K 0.01% 412
2016
Q3
$1.67M Sell
19,730
-1,031
-5% -$86.6K 0.01% 422
2016
Q2
$1.69M Buy
20,761
+384
+2% +$29.2K 0.01% 413
2016
Q1
$1.46M Buy
20,377
+107
+0.5% +$7.18K 0.01% 447
2015
Q4
$1.44M Sell
20,270
-2,296
-10% -$154K 0.01% 438
2015
Q3
$1.39M Sell
22,566
-207
-0.9% -$14.5K 0.01% 434
2015
Q2
$1.65M Sell
22,773
-200
-0.9% -$14.8K 0.01% 418
2015
Q1
$1.76M Sell
22,973
-80
-0.3% -$5.73K 0.01% 405
2014
Q4
$1.55M Sell
23,053
-2,784
-11% -$176K 0.01% 425
2014
Q3
$1.57M Sell
25,837
-1,994
-7% -$123K 0.01% 461
2014
Q2
$1.63M Sell
27,831
-802
-3% -$47K 0.01% 470
2014
Q1
$1.66M Sell
28,633
-2,420
-8% -$130K 0.01% 460
2013
Q4
$1.66M Buy
31,053
+4,106
+15% +$244K 0.01% 436
2013
Q3
$1.67M Sell
26,947
-399
-1% -$23.9K 0.01% 422
2013
Q2
$1.66M Buy
+27,346
New +$1.63M 0.01% 407

Other funds holding DGX

CIBC Asset Management's DGX Position: Q2 2026 in Review

CIBC Asset Management increased its Quest Diagnostics (DGX) stake by 7.9% in Q2 2026, buying an estimated $1.13M and bringing the position to 78,671 shares worth $16.7M. The position accounts for 0.04% of the portfolio, ranked #314.

CIBC Asset Management first reported a position in DGX in Q2 2013 and has held it in 53 quarters since. 1,099 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • CIBC Asset Management held 78,671 shares of Quest Diagnostics worth $16.7M as of Q2 2026.
  • CIBC Asset Management bought 5,774 Quest Diagnostics shares in Q2 2026, an estimated $1.13M.
  • Quest Diagnostics made up 0.04% of CIBC Asset Management's portfolio in Q2 2026, its #314 holding.
  • CIBC Asset Management first reported a position in Quest Diagnostics in Q2 2013 and has held it in 53 quarters since.
  • 1,099 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on CIBC Asset Management's 13F filing for Q2 2026, filed 3 Aug 2026.